drugset / Trial / NCT00866229

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level

NCT00866229

Phase 4 Unknown 140 enrolled Ramathibodi Hospital AstraZeneca · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Early statin therapy in SLE patients that have high cholesterol level and other atherosclerosis risk should reduce atherosclerosis and coronary artery events in later course of disease. By the way, statin is used in restricted groups of rheumatologists due to awareness of side effects; myositis and hepatitis, that are frequently found in SLE patients more so than other groups of atherosclerosis patients and reporting data of autoimmune diseases that occur after statin use.

Timeline

Start
2008-04
Primary completion
2010-03
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg
Subject Simvastatin Small molecule 20 mg